Next Generation Cancer Diagnostics Market Size, Share & Trends Report

Next Generation Cancer Diagnostics Market Size, Share & Trends Analysis Report By Technology (LOAC & RT-PCR, Protein Microarrays), By Application, By Cancer Type, By Function, By Region, And Segment Forecasts, 2023 - 2030

Report ID: 978-1-68038-738-4
Number of Report Pages: 236
Format: PDF, Horizon Databook

Historical Range: 2018 - 2021
Forecast Period: 2023 - 2030
Industry: Healthcare

Market Segmentation

Next-generation Cancer Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Next-generation Sequencing
- qPCR & Multiplexing
- Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
- Protein Microarrays
- DNA Microarrays
Next-generation Cancer Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Biomarker Development
- CTC Analysis
- Proteomic Analysis
- Epigenetic Analysis
- Genetic Analysis
Next-generation Cancer Diagnostics Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Others
Next-generation Cancer Diagnostics Function Outlook (Revenue, USD Million, 2018 - 2030)
- Therapeutic Monitoring
- Companion Diagnostics
- Prognostics
- Cancer Screening
- Risk Analysis
Next-generation Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Next-generation Cancer Diagnostics Market, By Technology
    - Next-generation Sequencing
    - qPCR & Multiplexing
    - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
    - Protein Microarrays
    - DNA Microarrays
  - North America Next-generation Cancer Diagnostics Market, By Application
    - Biomarker Development
    - CTC Analysis
    - Proteomic Analysis
    - Epigenetic Analysis
    - Genetic Analysis
  - North America Next-generation Cancer Diagnostics Market, By Cancer Type
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Cervical Cancer
    - Others
  - North America Next-generation Cancer Diagnostics Market, By Function
    - Therapeutic Monitoring
    - Companion Diagnostics
    - Prognostics
    - Cancer Screening
    - Risk Analysis
  - U.S.
    - U.S. Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - U.S. Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - U.S. Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - U.S. Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Canada
    - Canada Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Canada Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Canada Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Canada Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
- Europe
  - Europe Next-generation Cancer Diagnostics Market, By Technology
    - Next-generation Sequencing
    - qPCR & Multiplexing
    - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
    - Protein Microarrays
    - DNA Microarrays
  - Europe Next-generation Cancer Diagnostics Market, By Application
    - Biomarker Development
    - CTC Analysis
    - Proteomic Analysis
    - Epigenetic Analysis
    - Genetic Analysis
  - Europe Next-generation Cancer Diagnostics Market, By Cancer Type
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Cervical Cancer
    - Others
  - Europe Next-generation Cancer Diagnostics Market, By Function
    - Therapeutic Monitoring
    - Companion Diagnostics
    - Prognostics
    - Cancer Screening
    - Risk Analysis
  - UK
    - UK Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - UK Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - UK Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - UK Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Germany
    - Germany Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Germany Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Germany Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Germany Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - France
    - France Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - France Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - France Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - France Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Italy
    - Italy Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Italy Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Italy Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Italy Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Spain
    - Spain Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Spain Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Spain Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Spain Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Denmark
    - Denmark Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Denmark Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Denmark Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Denmark Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Sweden
    - Sweden Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Sweden Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Sweden Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Sweden Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Norway
    - Norway Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Norway Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Norway Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Norway Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
- Asia Pacific
  - Asia Pacific Next-generation Cancer Diagnostics Market, By Technology
    - Next-generation Sequencing
    - qPCR & Multiplexing
    - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
    - Protein Microarrays
    - DNA Microarrays
  - Asia Pacific Next-generation Cancer Diagnostics Market, By Application
    - Biomarker Development
    - CTC Analysis
    - Proteomic Analysis
    - Epigenetic Analysis
    - Genetic Analysis
  - Asia Pacific Next-generation Cancer Diagnostics Market, By Cancer Type
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Cervical Cancer
    - Others
  - Asia Pacific Next-generation Cancer Diagnostics Market, By Function
    - Therapeutic Monitoring
    - Companion Diagnostics
    - Prognostics
    - Cancer Screening
    - Risk Analysis
  - Japan
    - Japan Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Japan Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Japan Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Japan Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - China
    - China Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - China Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - China Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - China Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - India
    - India Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - India Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - India Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - India Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Australia
    - Australia Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Australia Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Australia Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Australia Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - South Korea
    - South Korea Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - South Korea Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - South Korea Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - South Korea Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Thailand
    - Thailand Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Thailand Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Thailand Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Thailand Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
- Latin America
  - Latin America Next-generation Cancer Diagnostics Market, By Technology
    - Next-generation Sequencing
    - qPCR & Multiplexing
    - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
    - Protein Microarrays
    - DNA Microarrays
  - Latin America Next-generation Cancer Diagnostics Market, By Application
    - Biomarker Development
    - CTC Analysis
    - Proteomic Analysis
    - Epigenetic Analysis
    - Genetic Analysis
  - Latin America Next-generation Cancer Diagnostics Market, By Cancer Type
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Cervical Cancer
    - Others
  - Latin America Next-generation Cancer Diagnostics Market, By Function
    - Therapeutic Monitoring
    - Companion Diagnostics
    - Prognostics
    - Cancer Screening
    - Risk Analysis
  - Brazil
    - Brazil Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Brazil Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Brazil Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Brazil Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Mexico
    - Mexico Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Mexico Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Mexico Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Mexico Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Argentina
    - Argentina Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Argentina Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Argentina Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Argentina Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
- MEA
  - MEA Next-generation Cancer Diagnostics Market, By Technology
    - Next-generation Sequencing
    - qPCR & Multiplexing
    - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
    - Protein Microarrays
    - DNA Microarrays
  - MEA Next-generation Cancer Diagnostics Market, By Application
    - Biomarker Development
    - CTC Analysis
    - Proteomic Analysis
    - Epigenetic Analysis
    - Genetic Analysis
  - MEA Next-generation Cancer Diagnostics Market, By Cancer Type
    - Lung Cancer
    - Breast Cancer
    - Colorectal Cancer
    - Cervical Cancer
    - Others
  - MEA Next-generation Cancer Diagnostics Market, By Function
    - Therapeutic Monitoring
    - Companion Diagnostics
    - Prognostics
    - Cancer Screening
    - Risk Analysis
  - South Africa
    - South Africa Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - South Africa Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - South Africa Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - South Africa Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Saudi Arabia
    - Saudi Arabia Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Saudi Arabia Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Saudi Arabia Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Saudi Arabia Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - UAE
    - UAE Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - UAE Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - UAE Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - UAE Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis
  - Kuwait
    - Kuwait Next-generation Cancer DiagnosticsMarket, By Technology
      - Next-generation Sequencing
      - qPCR & Multiplexing
      - Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
      - Protein Microarrays
      - DNA Microarrays
    - Kuwait Next-generation Cancer DiagnosticsMarket, By Application
      - Biomarker Development
      - CTC Analysis
      - Proteomic Analysis
      - Epigenetic Analysis
      - Genetic Analysis
    - Kuwait Next-generation Cancer DiagnosticsMarket, By Cancer Type
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Kuwait Next-generation Cancer DiagnosticsMarket, By Function
      - Therapeutic Monitoring
      - Companion Diagnostics
      - Prognostics
      - Cancer Screening
      - Risk Analysis

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.